References

Controversies in orthopaedic oncology

10.1302/0301-620x.106b5.bjj-2023-1381 · 2024 · External reference

A modified Delphi consensus on periprosthetic infection in orthopaedic oncology: a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)

2025 · External reference

Identifying consensus and areas for future research in chondrosarcoma: a report from the Birmingham Orthopaedic Oncology Meeting

10.1302/0301-620x.107b2.bjj-2024-0643.r1 · 2025 · External reference

Chondrosarcoma: clinical behavior, molecular mechanisms, and emerging therapeutic strategies

10.1016/j.critrevonc.2025.105075 · 2026 · External reference

Chondrosarcoma: a comprehensive review of tumor biology, clinical behavior, and therapeutic advances

10.1016/j.ctrv.2026.103197 · 2026 · External reference

MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma

10.1016/j.jbo.2026.100761 · 2026 · External reference

A deep learning model for classification of chondroid tumors on CT images

10.1186/s12885-025-13951-1 · 2025 · External reference

Chondrosarcoma of the flat bones: differential survival between high-grade lesions of the pelvis and scapula

10.1002/jso.28023 · 2025 · External reference

Core needle biopsy of periacetabular chondrosarcoma often results in undergrading but does not change management by experienced orthopaedic oncologists

10.1038/s41598-025-93246-4 · 2025 · External reference

Enhancing surgical margins: a key to survival in pelvic chondrosarcoma

10.1016/j.ejso.2024.109491 · 2025 · External reference

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma

10.1186/s13059-025-03812-2 · 2025 · External reference

Are IDH1 R132 mutations associated with poor prognosis in patients with chondrosarcoma of the bone?

10.1097/corr.0000000000002960 · 2024 · External reference

Prognostic role of TERT mutations in chondrosarcoma: associations with dedifferentiation, survival, and IDH/TERT co-mutations

10.3390/cancers18142272 · 2026 · External reference

Phase I study of the mutant IDH1 inhibitor ivosidenib: long-term safety and clinical activity in patients with conventional chondrosarcoma

10.1158/1078-0432.ccr-24-4128 · 2025 · External reference

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: Phase 1b/2 trial

10.1038/s41467-026-68716-6 · 2026 · External reference

Giant cell tumor of bone: biology, pathophysiology, and histopathology in the era of H3F3A

10.3390/biomedicines14020449 · 2026 · External reference

Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants

10.1016/j.jbo.2025.100728 · 2025 · External reference

Exploring denosumab in the treatment of giant cell tumors: clinical evidence and controversies

10.1097/scs.0000000000010880 · 2025 · External reference

[Update on the recommendations for the management and treatment of giant cell bone tumors, on behalf of GroupOS]

10.1016/j.bulcan.2024.01.013 · 2025 · External reference

What’s new on giant cell tumor of bone

10.1051/sicotj/2025063 · 2026 · External reference

Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis

10.1007/s11999-014-3699-2 · 2015 · External reference

What is the survival and function of modular reverse total shoulder prostheses in patients undergoing tumor resections in whom an innervated deltoid muscle can be preserved?

10.1097/corr.0000000000000899 · 2019 · External reference

Current treatment options and emerging technologies for pelvic bone tumors: from limb salvage to precision oncology

10.1007/s11864-026-01406-z · 2026 · External reference

Personalized 3D-printed prostheses for bone defect reconstruction after tumor resection in the foot and ankle

10.3390/jfb16020062 · 2025 · External reference

Reconstruction with 3D-printed prostheses after type I + II + III internal hemipelvectomy: finite element analysis and preliminary outcomes

10.3389/fbioe.2022.1036882 · 2023 · External reference

3D printing for patient-specific implants in musculoskeletal oncology

10.1530/eor-23-0066 · 2023 · External reference

A retrospective study of 3D-printed custom titanium prostheses for reconstruction of bone defects after resection of pelvic tumors: technical points and early results

10.1186/s12893-025-03253-5 · 2025 · External reference

Implementation of an intraoperative augmented reality environment for custom-made partial pelvis replacements-a proof of concept and initial results

10.3390/jpm16020124 · 2026 · External reference

Reconstruction with 3D-printed pelvic endoprostheses after resection of a pelvic tumour

10.1302/0301-620x.99b2.bjj-2016-0654.r1 · 2017 · External reference

Should the pelvic ring be closed after tumor resection? A systematic review

10.3390/cancers18111828 · 2026 · External reference

New options and techniques in reconstructing the sacrum

10.1007/s00586-025-09058-7 · 2026 · External reference

Modified spinopelvic fixation with a novel three-dimensional-printed element following total sacrectomy for patients with sacral tumours

10.1007/s00586-026-10008-0 · 2026 · External reference

Can periprosthetic joint infection of tumor prostheses be controlled with debridement, antibiotics, and implant retention?

10.1097/corr.0000000000003184 · 2025 · External reference

Microbiological characteristics and clinical outcomes of periprosthetic infections following oncologic megaprosthetic reconstruction: a retrospective cohort study

10.3390/pathogens15030306 · 2026 · External reference

Debridement, antibiotics, and implant retention (DAIR) plus offers similar periprosthetic joint infection treatment success rates to two-stage revision in oncologic megaprosthesis

10.1016/j.arth.2024.01.021 · 2024 · External reference

Treatment success of periprosthetic joint infections in oncologic endoprostheses after standardization of surgical strategies-a systematic review of the literature

10.5435/jaaos-d-25-00523 · 2026 · External reference

BOOM Consortium. Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours: a systematic review and meta-analysis

10.1302/2633-1462.76.bjo-2026-0037.r1 · 2026 · External reference

Surgical site infections following pelvic sarcoma reconstruction with 3D-printed implants: current concepts and future directions

10.1089/sur.2024.319 · 2025 · External reference

Periacetabular resection for bone tumors: is there still a role for massive allograft-prosthesis composite reconstructions?

10.1097/corr.0000000000003754 · 2026 · External reference

Bridging the gap: biological reconstruction with vascularised fibula, massive allograft, or Capanna technique after intercalary resection in children and young adults with lower limb bone sarcoma

2026 · External reference

Management of limb length discrepancy after bone sarcoma resection about the knee in the skeletally immature

10.1097/bpb.0000000000001124 · 2024 · External reference

Reconstruction of internal hemipelvectomy defects after oncologic Resection

10.5435/jaaos-d-23-00502 · 2025 · External reference

Radiological outcome in reverse shoulder arthroplasty does not correlate with patient satisfaction or quality of life

10.1016/j.jse.2024.11.004 · 2025 · External reference

Novel 3D-printed reverse shoulder prosthesis for reconstruction after resection of the scapular: a report of 2 cases

10.2106/jbjs.cc.24.00397 · 2025 · External reference

Evaluation of the long-term functional outcome and quality of life after rotationplasty in the management of primary malignant bone tumors about the knee in children

10.1051/sicotj/2026023 · 2026 · External reference

Factors affecting surgical outcomes following rotationplasty in paediatric sarcoma: a literature review

10.1111/ans.70842 · 2026 · External reference

Endoprosthetic use in pediatric and adolescent lower limb sarcoma treatment

10.5435/jaaos-d-25-00214 · 2026 · External reference

Evaluation of the mechanical failure of noninvasive expandable prostheses: a retrospective service evaluation of a UK Health Service

10.1097/bpo.0000000000003350 · 2026 · External reference

Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS-2 trial

10.1158/1078-0432.ccr-25-0649 · 2025 · External reference

Is there a role for mifamurtide in nonmetastatic high-grade osteosarcoma? Results from the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) trials

10.1200/jco-25-00210 · 2025 · External reference

Emerging nanocarrier strategies for optimized drug delivery in the treatment of primary bone cancer

10.32604/or.2026.077723 · 2026 · External reference

A 3D bioprinted spheroid-laden dECM-enriched osteosarcoma model for enhanced drug testing and therapeutic discovery

10.1002/adhm.202503633 · 2026 · External reference

Nanoparticle-driven reactive oxygen species therapy: a new frontier in osteosarcoma treatment

10.1016/j.jconrel.2025.114289 · 2025 · External reference

Intensified induction therapy for newly diagnosed, localized skeletal Ewing sarcoma (ISG/AIEOP EW-1): a randomized, open-label, Phase 3, non-inferiority trial

10.1002/pbc.31551 · 2025 · External reference

Addition of zoledronic acid to consolidation chemotherapy in Ewing sarcoma-EURO EWING 2012 (EE2012): an international, open-label, randomised controlled Phase III trial

10.1038/s41416-026-03367-4 · 2026 · External reference

The therapeutic potential of exosomes in bone cancers: osteosarcoma, chondrosarcoma, and Ewing sarcoma

10.1007/s10637-025-01551-6 · 2025 · External reference

Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: recent advancements

10.1016/j.critrevonc.2024.104575 · 2025 · External reference

Immunotherapy in pediatric bone sarcomas: current progress and future directions

10.1080/21645515.2026.2690876 · 2026 · External reference

Reprogramming adoptive cell therapy for osteosarcoma: engineering, vaccination, and tumor microenvironment remodeling

10.3389/fimmu.2026.1865742 · 2026 · External reference

Harnessing the immune responses: a new frontier in Ewing sarcoma treatment

10.1007/s12032-025-02848-5 · 2025 · External reference

Targeting strategies and immune regulatory mechanisms of CAR-macrophages in the treatment of osteosarcoma

10.1016/j.coph.2025.102602 · 2026 · External reference

Reducing complications after resection of pelvic bone sarcomas: an aggregation of marginal gains

2026 · External reference

Long-term outcomes of computer navigation-assisted resection for primary pelvic sarcomas

10.1302/0301-620x.107b5.bjj-2024-0732.r2 · 2025 · External reference

Machine learning-assisted decision making in orthopaedic oncology

10.2106/jbjs.rvw.24.00057 · 2024 · External reference

The emerging role of mixed reality and artificial intelligence in sarcoma care: a systematic review

10.1016/j.ejso.2026.111447 · 2026 · External reference

Diagnostic performance of artificial intelligence in detection of hepatocellular carcinoma: a meta-analysis

10.1007/s10278-024-01058-1 · 2024 · External reference

Intelligent nanomedicine systems utilizing diverse nanoparticles for osteosarcoma therapy: a review

10.2147/ijn.s560865 · 2025 · External reference

Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis

10.1186/s12885-025-13631-0 · 2025 · External reference

Artificial intelligence and machine learning in bone metastasis management: a narrative review

10.3390/curroncol33010065 · 2026 · External reference

Artificial intelligence in bone metastasis analysis: current advancements, opportunities and challenges

10.1016/j.compbiomed.2025.110372 · 2025 · External reference

The application of orthopedic surgical robot-assisted technology in various clinical scenarios involving bone tumors

10.1111/os.70195 · 2026 · External reference

Advances in liquid biopsy for bone and soft-tissue sarcomas

10.1007/s10147-025-02813-2 · 2025 · External reference

Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review

10.1007/s00402-024-05711-w · 2025 · External reference

Neoadjuvant or adjuvant chemotherapy in soft-tissue sarcoma?

10.1007/s11912-024-01630-6 · 2025 · External reference

Preoperative sequential chemotherapy and hypofractionated radiotherapy combined with comprehensive surgical resection for high-risk soft tissue sarcomas: a retrospective study

10.3389/fonc.2024.1423151 · 2024 · External reference

Current approaches to the treatment of pediatric soft tissue sarcomas: rhabdomyosarcoma and nonrhabdomyosarcoma soft tissue sarcomas

10.1016/j.hoc.2025.04.004 · 2025 · External reference

Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma

10.1158/1078-0432.ccr-24-3485 · 2025 · External reference

The role of orthoplastic surgery in musculoskeletal oncology

10.1530/eor-2025-0062 · 2025 · External reference

Pedicled vastus lateralis myocutaneous flap for sacropelvic defects after wide oncologic resection: wound complications and outcomes

10.1002/jso.27006 · 2022 · External reference

Ortho-oncoplastic surgery in foot and ankle: a narrative overview on reconstruction of soft-tissue defects after oncologic resections

10.1002/micr.31168 · 2024 · External reference

Staged reconstruction is not necessary following oncologic resection of superficial myxofibrosarcoma

10.3390/cancers17223637 · 2025 · External reference

Prognostic biomarkers for overall survival in patients undergoing surgery for bone metastases: a pan-cancer study

10.3389/fmed.2025.1655245 · 2026 · External reference

Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer center

2026 · External reference

Pathologic fractures in primary bone tumors: a paradigm shift in management

10.1016/j.injury.2025.112853 · 2025 · External reference

Management of metastatic bone disease of the pelvis: current concepts

10.1007/s00068-023-02382-x · 2024 · External reference

The bone microenvironment and therapeutic resistance in spinal metastases: mechanisms and clinical implications

10.1016/j.jocn.2026.111928 · 2026 · External reference

Modern treatment of skeletal metastases: multidisciplinarity and the concept of oligometastasis in the recent literature

10.3390/curroncol32040226 · 2025 · External reference

Prognostic impact of oligometastases in orthopaedic surgery for metastatic bone disease

10.1177/10225536251315983 · 2025 · External reference

Efficacy and safety of microwave ablation for the treatment of pulmonary osteosarcoma oligometastases

10.1080/02656736.2026.2620735 · 2026 · External reference

The current role of cryoablation in the management of soft tissue and bone tumors: a narrative review

10.1016/j.clinimag.2025.110704 · 2026 · External reference

The IlluminOss photodynamic bone stabilization system: novel technology with broad application in orthopaedic fracture fixation

10.1080/17434440.2026.2627378 · 2026 · External reference

Peri-operative outcomes of IlluminOss fixation for pelvic metastatic bone disease

10.1016/j.jor.2024.09.016 · 2024 · External reference

Bone metastases in NSCLC: modern paradigms in management and supportive care

10.1016/j.ctrv.2025.103051 · 2026 · External reference

Feasibility of nonspinal bony landmark-based image registration in CyberKnife ® robotic radiotherapy for pelvic and femoral bone tumors

10.1093/jrr/rrag028 · 2026 · External reference

Global consensus on the management of primary localized chordoma

10.1001/jamaoncol.2026.2054 · 2026 · External reference

Proton beam therapy for chordoma: a systematic review and meta-analysis

10.1016/j.critrevonc.2025.105013 · 2026 · External reference

Therapeutic strategies for mobile spine chordoma: en bloc versus intralesional surgery with adjuvant charged-particle therapy

10.1007/s11060-024-04841-w · 2025 · External reference

Sacral chordomas: surgical management, reconstruction, and translational advances: a systematic review

10.21037/jss-25-180 · 2026 · External reference

AAOS Clinical Practice Guideline Summary: treatment of metastatic carcinoma and myeloma of the femur

10.5435/jaaos-d-21-00888 · 2023 · External reference

A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial

10.1186/s13063-024-08590-z · 2024 · External reference